GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma

GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma

Gastric cancer is one of the cancers with the highest incidence in the world. Gamma-glutamyltransferase 5 (GGT5) is expressed in different cancers and its role in cancers remains unclear. In this study, we aimed to evaluate the value of GGT5 in stomach adenocarcinoma (STAD). In TCGA, patients with h...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yong Huang, HaiLang Zhou, Junwei Zou, Dong Wang
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2022/9983351
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The prognostic and immunomodulatory role of the MMR system in patients with stomach adenocarcinoma
by: Zhihui Tian, et al.
Published: (2025-01-01)

GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma
by: Lin Ni, et al.
Published: (2023-01-01)

Adenocarcinoma of the Stomach in Celiac Disease
by: Patricia J. Westlake, et al.
Published: (1989-01-01)

Integrating multiomics analysis and machine learning to refine the molecular subtyping and prognostic analysis of stomach adenocarcinoma
by: Miaodong Wang, et al.
Published: (2025-01-01)

Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
by: Ziyi Zhou, et al.
Published: (2025-02-01)

New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
by: Rocío del Campo-Pedrosa, et al.
Published: (2024-10-01)

Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma
by: Yue-Hua Zhang, et al.
Published: (2018-01-01)

DCUN1D5 is a prognostic biomarker and correlated immune infiltrates and glycolysis in lung adenocarcinoma
by: Song Zhao, et al.
Published: (2025-01-01)

Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
by: Rocío del Campo-Pedrosa, et al.
Published: (2025-01-01)

SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma
by: Lianxiang Luo, et al.
Published: (2021-01-01)

Biomarkers of gastric atrophy at stomach cancer
by: A. V. Belkovets, et al.
Published: (2018-08-01)

NT5E (CD73) as a prognostic biomarker and therapeutic target associated with immune infiltration in lung adenocarcinoma
by: Leyan Chen, et al.
Published: (2025-02-01)

The role of LMNB2 as a diagnostic and prognostic biomarker in lung adenocarcinoma
by: Shengshan Xu, et al.
Published: (2025-02-01)

Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma
by: Heike Loeser, et al.
Published: (2020-01-01)

Characterizing the Crosstalk of NCAPG with Tumor Microenvironment and Tumor Stemness in Stomach Adenocarcinoma
by: Zheng Xiang, et al.
Published: (2022-01-01)

TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma
by: Feiming Hu, et al.
Published: (2025-01-01)

Elevated GGT to HDL ratio as a marker for the risk of NAFLD and liver fibrosis
by: Yanyan Xuan, et al.
Published: (2025-01-01)

NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
by: Youlong Zhu, et al.
Published: (2025-01-01)

Hepatoid adenocarcinoma of the stomach with ideal response to neoadjuvant chemo-immunotherapy: a case report
by: Linchuan Li, et al.
Published: (2025-01-01)

Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients’ FOXP1 and GGT levels
by: Xinyu Guo, et al.
Published: (2025-01-01)

Highly proliferating cancer cells function as novel prognostic biomarkers for lung adenocarcinoma with particular usefulness for stage IA risk stratification
by: Yanlu Xiong, et al.
Published: (2025-01-01)

Pan-cancer and experimental analyses reveal the immunotherapeutic significance of CST2 and its association with stomach adenocarcinoma proliferation and metastasis
by: Dan Huang, et al.
Published: (2025-01-01)

Prognostic significance of α-fetoprotein in gastric adenocarcinoma
by: Sezgin Vatansever, et al.
Published: (2022-03-01)

Novel biomarkers: the RUNX family as prognostic predictors in colorectal cancer
by: Yingting Liu, et al.
Published: (2024-12-01)

Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma
by: Hui Tang, et al.
Published: (2022-01-01)

Total neoadjuvant chemotherapy according to the FOLFIRINOX regimen for locally advanced adenocarcinoma of the stomach and cardioesophageal junction: interim results
by: M. V. Sedova, et al.
Published: (2023-09-01)

SMR-guided molecular subtyping and machine learning model reveals novel prognostic biomarkers and therapeutic targets in non-small cell lung adenocarcinoma
by: Baozhen Wang, et al.
Published: (2025-01-01)

SOX-9 as a prognostic marker in gastric adenocarcinoma
by: Efe Yetişgin, et al.
Published: (2025-01-01)

CHST1 as a prognostic-related biomarker in gastric cancer correlating with immune infiltration
by: Long Gui, et al.
Published: (2025-02-01)

Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma
by: Guanxiang Zhuo, et al.
Published: (2025-01-01)

Comprehensive Analysis of the Expression, Prognostic Value, and Immune Infiltration Activities of GABRD in Colon Adenocarcinoma
by: Fakun Huang, et al.
Published: (2023-01-01)

GPX3-Mediated Oxidative Stress Affects Pyrimidine Metabolism Levels in Stomach Adenocarcinoma via the AMPK/mTOR Pathway
by: Yaowen Zhang, et al.
Published: (2024-01-01)

The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancer
by: Yi Zhao, et al.
Published: (2025-01-01)

Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study
by: Dawei Jiang, et al.
Published: (2021-01-01)

Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas
by: Ozden Oz, et al.
Published: (2023-07-01)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
by: Florian Gebauer, et al.
Published: (2017-01-01)

MRTX1133 attenuates KRASG12D mutated-colorectal cancer progression through activating ferroptosis activity via METTL14/LINC02159/FOXC2 axis
by: Junwei Zou, et al.
Published: (2025-02-01)

Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker
by: Yaoting Zhang, et al.
Published: (2022-01-01)

CDK5RAP2: A potential prognostication biomarker for oral squamous cell carcinoma?
by: Benson Paul, et al.
Published: (2024-06-01)

Epidemiological Features of Sinonasal Adenocarcinoma and Prognostic Nomogram: A Study Based on the SEER Database
by: Lu Yang MMed, et al.
Published: (2025-01-01)